Evidence for Predominance of CCR5-Using HIV-1 Strains During Highly Active Antiretroviral Therapy

E-ISSN： 1873-4251|5|2|221-234

ISSN： 1570-162X

Source： Current HIV Research, Vol.5, Iss.2, 2007-03, pp. : 221-234

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Effects of Highly Active Antiretroviral Therapy on HIV-1-Associated Oral Complications

Current HIV Research, Vol. 5, Iss. 3, 2007-05 ,pp. : 281-292

Bentham Science Publishers

Access to resources Recommend Favorite

Nitric oxide in HIV-1 perinatally infected children treated with highly active antiretroviral therapy

By Chiappini E. Galli L. Azzari C. de Martino M.

The Lancet Infectious Diseases, Vol. 3, Iss. 3, 2003-03 ,pp. : 128-129

Elsevier

Access to resources Recommend Favorite

Nitric oxide in HIV-1 perinatally infected children treated with highly active antiretroviral therapy

By Torre D.

The Lancet Infectious Diseases, Vol. 3, Iss. 3, 2003-03 ,pp. : 129-130

Elsevier

Access to resources Recommend Favorite

Cerebrovascular Ischemic Events in HIV-1-Infected Patients Receiving Highly Active Antiretroviral Therapy: Incidence and Risk Factors

Cerebrovascular Diseases, Vol. 27, Iss. 6, 2009-04 ,pp. : 559-563

Karger

Access to resources Recommend Favorite

Prospective Observation for Seven-Year's Highly Active Antiretroviral Therapy in Chinese HIV-1 Infected Patients

Current HIV Research, Vol. 9, Iss. 3, 2011-04 ,pp. : 160-165

Bentham Science Publishers

Access to resources Recommend Favorite